DMTK
DermTech Inc

4,562
Loading...
Loading...
News
all
press releases
Crude Oil Rises 1%; DermTech Shares Plummet
read more...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
DermTech Files for Voluntary Chapter 11 Protection
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the...
Business Wire·1y ago
News Placeholder
DermTech Reports First-Quarter 2024 Financial Results
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter 2024 financial results...
Business Wire·1y ago
News Placeholder
What Analysts Are Saying About DermTech Stock
Latest Ratings for DMTK DateFirmActionFromTo Jan 2022Stephens & Co.Initiates Coverage OnOverweight May 2021BTIGInitiates Coverage OnBuy Jan 2021OppenheimerInitiates Coverage OnOutperform View...
Benzinga·1y ago
News Placeholder
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board...
Business Wire·1y ago
News Placeholder
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that effective March 27, 2024, the...
Business Wire·1y ago
News Placeholder
DermTech (NASDAQ:DMTK) vs. Fortrea (NASDAQ:FTRE) Financial Analysis
Fortrea (NASDAQ:FTRE Get Free Report) and DermTech (NASDAQ:DMTK Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses...
Zolmax·2y ago
News Placeholder
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentation of two research...
Business Wire·2y ago
News Placeholder
DermTech (NASDAQ:DMTK) Price Target Lowered to $1.50 at Stephens
DermTech (NASDAQ:DMTK Free Report) had its price objective trimmed by Stephens from $2.50 to $1.50 in a report issued on Tuesday morning, Benzinga reports. The firm currently has an equal...
Zolmax·2y ago
News Placeholder
Q4 2023 DermTech Inc Earnings Call Transcript
Related Stocks: NAS:DMTK...
GuruFocus·2y ago

Latest DMTK News

View

Advertisement. Remove ads.

Advertisement. Remove ads.